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Summary
Familial hemiplegic migraine (HM) is an autosomal
dominant migraine with aura. In 20% of HM families,
HM is associated with a mild permanent cerebellar
ataxia (PCA). The CACNA1A gene encoding the a1A
subunit of P/Q-type voltage-gated calcium channels is
involved in 50% of unselected HM families and in all
families with HM/PCA. Four CACNA1A missense mu-
tations have been identified in HM: two in pure HM
and two in HM/PCA. Different CACNA1A mutations
have been identified in other autosomal dominant con-
ditions: mutations leading to a truncated protein in ep-
isodic ataxia type 2 (EA2), small expansions of a CAG
trinucleotide in spinocerebellar ataxia type 6 and also
in three families with EA2 features, and, finally, a mis-
sense mutation in a single family suffering from episodic
ataxia and severe progressive PCA. We screened 16 fam-
ilies and 3 nonfamilial case patients affected by HM/
PCA for specific CACNA1A mutations and found nine
families and one nonfamilial case with the same T666M
mutation, one new mutation (D715E) in one family, and
no CAG repeat expansion. Both T666M and D715E
substitutions were absent in 12 probands belonging to
pure HM families whose disease appears to be linked to
CACNA1A. Finally, haplotyping with neighboring
markers suggested that T666M arose through recurrent
mutational events. These data could indicate that the
PCA observed in 20% of HM families results from spe-
cific pathophysiologic mechanisms.
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Introduction
Familial hemiplegic migraine (HM; MIM 141500) is an
autosomal dominant form of migraine with aura (Blau
and Whitty 1955; Headache Classification Committee
of the International Headache Society [IHS] 1988). Typ-
ical attacks include a unilateral motor deficit associated
with paresthesias, speech disturbances, or visual signs.
These aura symptoms last from 10 min to a few hours
and are followed by a migrainous headache. In 20% of
unselected families, some HM patients have permanent
cerebellar symptoms, such as nystagmus and slowly pro-
gressive mild to moderate statokinetic ataxia. In some
cases, cerebral magnetic resonance imaging reveals cer-
ebellar atrophy. Cerebellar ataxia may be diagnosed
prior to the first HM attack and progresses indepen-
dently of the frequency and/or severity of these attacks.
Autonomous gait remains generally possible, even after
years of evolution (Ohta et al. 1967; Young et al. 1970;
Zifkin et al. 1980; Fitzsimons and Wolfenden 1985; Jou-
tel et al. 1993, 1994; Ophoff et al. 1994; Elliott et al.
1996; Terwindt et al. 1998). HM has been shown to be
genetically heterogeneous (Joutel et al. 1994; Ophoff et
al. 1994; Ducros et al. 1997).
The first responsible gene, located on chromosome
19p13.1 (Joutel et al. 1993), was identified in 1996 as
being CACNA1A, which encodes the main pore-forming
a1A subunit of P/Q-type voltage-gated calcium channels
(Ophoff et al. 1996). These channels are expressed in a
large variety of neurons, in which they play an important
role in the control of membrane excitability, neurotrans-
mitter release, and gene expression (Catterall et al.
1995). They are the predominant calcium channel in
Purkinje cells (P-type currents) and are highly expressed
in cerebellar granule cells (P- and Q-type currents) (Lli-
nas et al. 1992; Stea et al. 1994; Westenbroek et al.
1995). CACNA1A has been determined to be involved
(on the basis of linkage or mutation screening data) in
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Table 1
No. of Sampled Individuals in the 16 HM/PCA Families
FAMILY
AFFECTED
HEALTHY
UNKNOWN
STATUS
NO. OF
SPOUSES TOTALTotal
Without
PCA With PCA
Not
Examined
F1 20 1 16 3 13 3 7 43
F2 5 ) 5 ) ) ) 2 7
F3 3 ) 3 ) 7 ) 1 11
F4 2 ) 1 1 1 2 ) 5
F5 17 6 11 ) 10 ) 6 33
F6 5 2 3 ) ) ) 2 7
F7 2 ) 2 ) ) ) 1 3
F8 1 ) 1 ) ) ) ) 1
F9 1 ) 1 ) ) ) ) 1
F10 13 7 5 1 2 ) 5 20
F11 6 ) 6 ) ) 4 5 15
F12 4 ) 4 ) 2 ) 1 7
F13 2 1 1 ) ) ) 1 3
F14 4 2 2 ) 1 ) 2 7
F15 1 ) 1 ) ) ) ) 1
F16 1 ) 1 ) ) ) ) 1
Total 87 19 63 5 36 9 33 165
all five families with HM and progressive cerebellar
ataxia (HM/PCA) reported thus far (Joutel et al. 1993;
1994; Ophoff et al. 1996; Terwindt et al. 1998). In con-
trast, pure HM has been linked to at least three different
genes: CACNA1A (Joutel et al. 1994; Ophoff et al.
1994; 1996); a second, unidentified gene mapped on
chromosome 1q21-q23 (Ducros et al. 1997; Gardner et
al. 1997); and at least a third gene, still to be localized
(Ducros et al. 1997).
Only six HM families—three with HM/PCA and three
with pure HM—have been screened thus far for
CACNA1A mutations (Ophoff et al. 1996; Terwindt et
al. 1998). In HM/PCA, two missense mutations have
been identified: T666M in one family and I1811L in two
unrelated families. In pure HM, two other missense mu-
tations have been detected: R192Q and V714A, each in
a single family. Because of the small number of families
analyzed to date, genotype-phenotype correlations have
not been possible.
Distinct types of CACNA1A mutations have been
identified in other neurologic conditions in which cer-
ebellar ataxia is the major symptom. Mutations leading
to protein truncation have been identified in familial and
sporadic episodic ataxia type 2 (EA2; MIM 108500),
which is characterized by recurrent attacks of parox-
ysmal ataxia associated with interictal cerebellar symp-
toms similar to those observed in HM/PCA (Ophoff et
al. 1996; Yue et al. 1998). Small expansions of a CAG
repeat, located within the 3′ end of the gene and pre-
dicted to code for a polyglutamine tract in three of the
six known human splice variants, are causing spinocer-
ebellar ataxia type 6 (SCA6; MIM 183086), a late-onset
moderate to severe permanent and progressive ataxia
(Zhuchenko et al. 1997). Surprisingly, CAG expansions
were also identified in three families with paroxysmal
and permanent progressive ataxia (Jodice et al. 1997;
Geschwind et al. 1997). Finally, a missense mutation was
detected in a single family in which patients suffered
from both paroxysmal episodes indistinguishable from
those observed in EA2 and a rapidly progressive and
very severe permanent ataxia (Yue et al. 1997).
Since only three HM/PCA families have been tested
so far, we analyzed a panel of 16 families and 3 non-
familial patients affected by this condition to search for
specific CACNA1A mutations, investigate the role of a
CAG expansion in this peculiar phenotype, and compare
chromosome 19 disease-linked haplotypes. Subse-
quently, the frequency of these HM/PCA mutations was
evaluated in 12 unrelated pure HM patients belonging
to families with linkage to chromosome 19p13.1.
Subjects and Methods
Familial Cases
From 1992 to 1997, 150 families fulfilling the IHS
criteria for HM (1988) were referred to our laboratory.
All subjects included in this study gave informed consent.
In total, 165 family members, including 33 spouses, were
interviewed directly, and most were examined by one of
the authors (table 1). The 16 families (F1–F16) in which
at least one HM patient had associated permanent cer-
ebellar symptoms were selected for the present study.
Pedigrees are shown in figure 1A. Families F1 and F10
were described as families A and J by Joutel et al. (1993,
1994). Both showed significant linkage to chromosome
Figure 1 T666M mutation in nine families and one nonfamilial case of HM/PCA. a, Pedigrees of the 16 families and the 3 nonfamilial
case patients. Individuals are represented as males (squares), females (circles), unaffected (unblackened symbol), affected (blackened symbol),
and having an unknown status (hatched symbol). A question mark (?) indicates subjects for whom no history was available. Probands are
indicated by an asterisk (∗). All living subjects represented on this figure were sampled, except in families F8, F9, F15, and F16, in which only
the proband was sampled, and the nonfamilial case S1, from whose parents blood had not been drawn. b, T666M abnormal conformers. SSCP
was performed with DNA from the 16 family probands and the 3 nonfamilial case patients. SSCP and DNA sequencing revealed the same
CrT substitution at codon 666, substituting a threonine for a methionine (T666M) in nine families (F1–F9) and in sporadic case S1. The
banding pattern of a normal control (N) is also shown. c, Cosegregation of the T666M mutation with HM/PCA was demonstrated by SSCP
in each multiplex family, as shown here for part of family F5. The numbering in this part of family F5 is given according to the gel lanes. All
affected members are heterozygous for the wild type and the mutant sequence, and all unaffected subjects (10 and 11) and unrelated spouses
(3, 7, and 14) are homozygous for the normal sequence.
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Table 2
Clinical and Genetic Features of the Families of the 12 Pure HM Probands
Family Affected Healthy
Unknown
Status Spouses Total
Linkage Analysis and Haplotyping
with Chromosome 19p Markers
P1 10 3 3 6 22 Zmax  2.49 at v  .01 from D19S226
P2 5 4 1 3 13 Zmax  1.68 at v  .00 from D19S906
P3 5 2 ) 2 9 Zmax  1.72 at v  .00 from D19S394
P4 6 1 2 3 12 Zmax  1.72 at v  .00 from D19S199
P5 6 4 2 3 15 Zmax  2.41 at v  .00 from D19S221
P6 6 2 1 2 11 No affected obligate recombinanta
P7 5 3 1 2 11 No affected obligate recombinanta
P8 3 1 ) 1 5 No affected obligate recombinanta
P9 3 ) ) ) 3 No affected obligate recombinanta
P10 3 ) ) 1 4 No affected obligate recombinanta
P11 6 ) ) 1 7 No affected obligate recombinanta
P12 4 4 ) 2 10 No affected obligate recombinanta
Total 62 24 10 26 122
a With intragenic markers D19S1150 and CAG.
19p13.1. Except for family F11, which originated from
Denmark, all families were from France. In four families
(F8, F9, F15, and F16), only the proband was sampled,
but at least one first-degree affected relative was inter-
viewed to confirm the hereditary nature of HM. All to-
gether, 87 subjects within the 16 families had hemiplegic
migraine attacks fulfilling the IHS diagnosis criteria
(1988) and were classified as affected. Among those HM
patients, 63 had permanent cerebellar symptoms such
as nystagmus and/or mild to moderate statokinetic cer-
ebellar ataxia, and 19 had normal neurologic findings
on examination; the last five patients could not be ex-
amined. Thirty-six at-risk individuals 115 years old were
free of any type of migraine, had normal neurologic
findings on examination, and were classified as healthy.
Finally, nine at-risk subjects had nonhemiplegic mi-
graine, isolated cerebellar symptoms, or both. Those
clinical features may be part of the phenotypic spectrum
of HM/PCA; however, in the absence of HM attacks,
these subjects were classified as having an unknown
status. Blood samples were collected from all of the 165
consenting family members.
Probands belonging to 12 pure HM families (P1–P12)
linked to chromosome 19p13.1 were also selected. These
families were identified on the basis of the IHS criteria
for HM and classified as affected by the pure form of
the condition on the basis of the absence of cerebellar
symptoms in any of the 96 at-risk family members who
were examined (table 2). Three of these families have
been reported by Joutel et al. (family P1 as family B in
1993, families P2 and P3 as families E and F in 1994).
Linkage analysis was conducted prior to the present
study. In brief, seven microsatellite markers spanning the
CACNA1A genetic interval on chromosome 19p and
including two intragenic markers (D19S1150 and the
CAG repeat) have been tested (Gyapay et al. 1994;
Ophoff et al. 1996). Within the five first families
(P1–P5), positive LOD scores were obtained with several
markers, including a maximum LOD score (Zmax) 11.5
with at least one marker. In the seven last families,
weakly positive LOD scores were obtained because of
the small size of the pedigrees and the lack of inform-
ativeness of several markers. However, haplotyping
using both intragenic markers has shown that all af-
fected subjects in families P6–P12 were carrying the
D19S1150-CAG disease-linked haplotype.
Nonfamilial Cases
Three sporadic case patients with HM and permanent
cerebellar symptoms were also analyzed (S1–S3). All
three patients fulfilled the IHS diagnosis criteria for HM
but did not have any affected relative. Blood was col-
lected from those three nonfamilial case patients and
from both parents of subjects S2 and S3.
Mutation Analysis
DNA was prepared according to standard procedures.
Mutation screening using SSCP analysis (Orita et al.
1989) was performed in the proband of each family and
in the three nonfamilial case patients. Sixty-four pairs
of primers were used to amplify the 47 published exons
and their corresponding 92 exon/intron boundaries. We
used 58 primers published by Ophoff et al. (1996) and
70 newly designed primers to limit the size of amplified
fragments to ∼200 bp and thus to optimize the sensitivity
of SSCP analysis (sequences of the new primers and de-
tails of the PCR conditions are available on request).
After electrophoresis of heat-denatured PCR products
on 10% acrylamide gels at 20C on a Mighty Small II
apparatus (Pharmacia-Biogen), the conformers were re-
vealed by means of the Silver Stain Plus kit (Bio-Rad),
according to the supplier’s protocol. Genomic DNA
samples from one unrelated normal individual were used
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as controls in each SSCP analysis. In the case of abnor-
mal SSCPs, the DNA sequence was determined by using
a dye-terminator cycle-sequencing kit (Perkin-Elmer) ac-
cording to the supplier’s instructions. For each DNA
sequence abnormality, cosegregation with the disorder
was analyzed by SSCP. For each of the three largest HM/
PCA families (F1, F5, and F10), a subset of 15 or 16
members was analyzed. In the other, smaller pedigrees,
cosegregation with the disease was analyzed with all
available family members. In addition, 100 unrelated
normal individuals and the 12 pure-HM probands were
tested, with SSCP analysis, for the absence of each mu-
tation cosegregating with the disease; PCR products
from those controls were run on the same gels as the
PCR product of a known mutation carrier.
Genetic Analysis
To identify the haplotypes cosegregating with HM/
PCA, all subjects were genotyped with four poly-
morphic markers: D19S221 and D19S226, which are
two CA repeats flanking the 6-cM interval containing
CACNA1A (Gyapay et al. 1994; Genome Database),
and two intragenic markers, D19S1150, which is a CA
repeat located in intron 7 of CACNA1A, and the CAG
repeat contained in exon 47. D19S1150 and the CAG
repeat are separated by a maximum of 350 kb (Ophoff
et al. 1996; Zhuchenko et al. 1997). PCR was performed
with published primers and conditions (Gyapay et al.
1996; Ophoff et al. 1996; Zhuchenko et al. 1997). The
frequencies of the D19S1150 alleles, determined by ge-
notyping 55 unrelated healthy individuals, including the
33 spouses sampled in this study, were as follows: 164
bp: 0.069; 162 bp: 0.009; 160 bp: 0.294; 158 bp: 0.157;
156 bp: 0.078; 154 bp: 0.009; 152 bp: 0.363; 150 bp:
0.009; and 148 bp: 0.009. The frequencies of the CAG
repeat alleles in the same control population were as
follows: CAG17: 0.009; CAG14: 0.009; CAG13: 0.309;
CAG12: 0.173; CAG11: 0.427; CAG7: 0.054; and
CAG4: 0.018. For D19S221 and D19S226, published
frequencies from CEPH families were used. No
D19S1150 allele was in linkage disequilibrium with a
CAG allele. The expected frequencies of the dinucleo-
tide- and trinucleotide-repeat alleles and of the haplo-
types of the studied families were calculated from the
frequencies observed in control subjects. Expected and
observed allele and haplotype frequencies in the affected
population were compared by means of the x2 test (with
Yates’s correction when necessary).
Results
T666M as a Predominant Mutation in HM/PCA
Mutations were identified in 10 of the 16 families and
in one of the three patients with nonfamilial HM. Only
two different missense mutations were detected through-
out the 47 exons and flanking intron sequences (table
3). The same CrT substitution in exon 16, causing a
threonine-for-methionine substitution at codon 666
(T666M), was found in nine families (F1–F9) (fig. 1).
Cosegregation with the disease was demonstrated in all
of these nine families by means of SSCP. This mutation
was shown to be absent in 200 normal chromosomes.
We also detected the T666M substitution in a nonfam-
ilial case (S1). In the absence of DNA samples from both
parents, false paternity or incomplete penetrance could
not be ruled out.
A new missense mutation located in exon 17, a CrA
substitution at codon 715, resulting in an aspartic acid-
to-glutamic acid substitution (D715E), was identified in
family F10 (figs. 2 and 3). Cosegregation with HM/PCA
was demonstrated by means of SSCP analysis. This mu-
tation was not detected in 200 control chromosomes.
No disease-associated mutation was detected in six
families (F11–F16). In addition, four polymorphisms
were observed in HM/PCA patients (table 4).
To establish that both T666M and D715E mutations
were strongly associated with the HM/PCA phenotype,
the 12 probands belonging to pure HM families linked
to chromosome 19p13.1 were screened by SSCP for the
abnormal conformer generated by each mutation. For
exon 16 (T666M), PCR products of the 12 pure HM
probands, 1 unrelated healthy control, and 1 T666M
mutation carrier were run on the same gel. The same
control procedure was used for exon 17 (D715E). No
abnormal conformer was observed in exons 16 and 17
of the 12 probands, demonstrating the absence of mu-
tations T666M and D715E.
Evidence against a Major Founder Effect in T666M
Patients
All HM/PCA families and nonfamilial case patients
were genotyped with the two intragenic markers,
D19S1150 and the CAG repeat, as well as the markers
flanking the 6-cM interval containing CACNA1A,
D19S221, and D19S226. Alleles and haplotypes cose-
gregating with the disease were established in 12 mul-
tiplex families (table 1). In the last four families (F8, F9,
F15, and F16) in which only the proband has been an-
alyzed, both alleles were taken into account. There was
no significant difference in the frequencies of the various
marker alleles in HM/PCA patients and normal controls,
except for one CAG allele. Indeed, this allele, CAG7, was
observed on HM/PCA chromosomes with a higher fre-
quency than on control chromosomes (observed fre-
quency  21.05%, expected frequency  5.45%,
, ). However, the frequency of this2x  6.20 P ! .02
CAG7 allele on chromosomes carrying T666M was not
significantly different from its frequency on other HM/
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Table 3
Haplotypes and Mutations in 16 Families (F1 to F16) and 3 Nonfamilial Case Patients (S1 to S3) Affected with
HM/PCA
FAMILY OR
NONFAMILIAL
SUBJECT
HAPLOTYPE CACNA1A MUTATION
D19S221 D19S1150 CAG D19S226 Exon Nucleotide Codon Domain
F1 199 160 13 251 16 aCgraTg T666M IIS5-S6 linker
F2 209a 164a 11a 243a 16 aCgraTg T666M IIS5-S6 linker
F3 209a 164a 11a 243a 16 aCgraTg T666M IIS5-S6 linker
F4 199 158 13 235 16 aCgraTg T666M IIS5-S6 linker
F5 205 160 7 245 16 aCgraTg T666M IIS5-S6 linker
F6 207b 156b 7b 243b 16 aCgraTg T666M IIS5-S6 linker
F7 207b 156b 7b 243b/247 16 aCgraTg T666M IIS5-S6 linker
F8 209/207 160/150 13/13 247/241 16 aCgraTg T666M IIS5-S6 linker
F9 205/191 160/152 12/11 245/235 16 aCgraTg T666M IIS5-S6 linker
S1 ) 158/156 12/11 245/253 16 aCgraTg T666M IIS5-S6 linker
F10 207 152 11 235 17 gaCrgaG D715E IIS6
F11 197 156 13 253 ) ) ) )
F12 207 152 12 245 ) ) ) )
F13 205 164 7 235 ) ) ) )
F14 211 160 12 235 ) ) ) )
F15 207/201 160/152 13/13 247/243 ) ) ) )
F16 ) 164/158 12/12 251/235 ) ) ) )
S2 203/197 156/150 13/13 241/235 ) ) ) )
S3 209/205 164/160 13/11 247/235 ) ) ) )
a Haplotype shared in families F2 and F3 (frequency in the 16 families: 12.5%; frequency expected: 0.028%;
).10P ! 10
b Haplotype shared in families F6 and F7 (frequency in the 16 families: 12.5%; frequency expected: 0.011%;
).10P ! 10
PCA chromosomes ( , not significant), which2x  0.195
did not favor a founder effect.
Within the nine families (F1–F9) with the T666M mu-
tation, affected haplotypes were established in seven
families (F1–F7): five different haplotypes were clearly
identified, strongly suggesting the absence of a major
founder effect. A common haplotype was found in fam-
ilies F2 and F3, but tracing of family trees to a common
ancestor was impossible because the parents of the trans-
mitter in family F2 were unknown. A second common
haplotype was shared in families F6 and F7. Again, trac-
ing of family trees to a common ancestor was impossible
because of the lack of information about ancestors in
family F7. In addition, the five distinct haplotypes ob-
served in kindreds F1–F7 were different from the various
combinations of alleles observed in familial cases F8 and
F9 and in the nonfamilial case S1, suggesting the exis-
tence of eight different genetic backgrounds for the same
T666M mutation. The haplotype cosegregating with the
D715E mutation in family F10 was not observed in any
other HM/PCA patient.
Finally, haplotypes segregating with the disease were
determined in four families without any identified
CACNA1A mutation (F11–F14). They were different
from one another, and comparison with the combination
of alleles observed in familial cases F15 and F16 and
sporadic cases S2 and S3 suggested the existence of a
total of eight different haplotypes in patients without
identified mutations.
Absence of CAG Repeat Expansion
The CAG repeat length was determined in all 16 fam-
ilies and 3 nonfamilial case patients affected with HM/
PCA. No intergenerational CAG repeat expansion was
observed. In the 90 affected subjects, the CAG stretch
ranged from 4 to 17 repeat units (mean 10.98), which
is not different from the range observed in the 55 normal
unrelated controls (range 4–17 repeats, mean 11.5).
The CAG allele cosegregating with HM/PCA was de-
termined in 15 families and 1 homozygous nonfamilial
case and ranged from 7 to 13 repeat units (table 1). The
CAG allele inherited from the healthy parent was de-
termined in 77 patients who had been examined. These
alleles in trans ranged from CAG4 to CAG13 in the 15
patients with normal neurologic findings and from CAG4
to CAG17 in the 63 patients with permanent cerebellar
symptoms. Allele CAG4 was observed more frequently
in patients with normal neurologic findings on exami-
nation ( , ), in only four patients (three2x  5.066 P ! .05
without and one with PCA). No difference was detected
in the frequencies of the other alleles between patients
with and without cerebellar symptoms.
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Figure 2 Mutation D715E in exon 17 of the CACNA1A gene
in family F10. a, SSCP and DNA sequence analysis of individual F10-
4 revealed a CrG substitution at codon 715, resulting in a substitution
of an aspartic acid for a glutamic acid. b, The cosegregation of this
mutation with HM/PCA was demonstrated in family F10 by the SSCP
analysis of 16 of the 20 family members. The numbering in this part
of family F10 is given according to the gel lanes. All affected members
are heterozygous (wt/m). All unaffected spouses are homozygous for
the wild-type sequence. Individual 9, a 24-year-old man free of any
migraine attack and with normal neurologic findings on examination,
is heterozygous (wt/m). In the 90 HM/PCA patients in this study, the
mean age of onset was 11.4 years old, but in 7% of those patients,
attacks started after 24 years of age. Individual 9 may represent an
instance of nonpenetrance or a case of delayed onset.
Discussion
We screened the CACNA1A gene in 16 families and
3 nonfamilial subjects affected by HM/PCA. Nine of the
16 families and 1 nonfamilial subject had the same
T666M mutation. This substitution was shown to be
absent in probands belonging to 12 unrelated pure HM
families linked to chromosome 19p13.1, indicating a
strong correlation between the T666M genotype and the
HM/PCA phenotype. Haplotyping, using four markers
including two intragenic ones (D19S1150 and the CAG
repeat), suggested that the predominance of T666M may
be due to recurrent mutations rather than to a founder
effect. Of interest, one of the three HM/PCA families
reported thus far also had the T666M mutation (Ophoff
et al. 1996).
Two other mutations have been identified in HM/
PCA: I1811L (Ophoff et al. 1996) and D715E (present
study). The I1811L mutation was detected in two HM/
PCA families, including one initially diagnosed as having
pure HM (Terwindt et al. 1998). Both families originated
from different countries (The Netherlands and the
United States) and displayed different disease haploty-
pes. Thus, two of the three missense mutations identified
thus far in HM/PCA are recurrent on different genetic
backgrounds, favoring the hypothesis of a restriction of
the number of CACNA1A substitutions susceptible to
producing this phenotype.
The CACNA1A gene codes for the main pore-forming
a1A subunit, which, in association with auxiliary b and
a2/d regulatory subunits, forms P/Q-type voltage-depen-
dent calcium channels (Catterall 1995; Gurnett and
Campbell 1996). a1A subunits control the voltage de-
pendence, ionic selectivity, and major gating kinetics of
P/Q-type channels. They are formed by four repeated
domains (I–IV), which contain six integral transmem-
brane segments (S1–S6). The positively charged S4 helix
represents the voltage sensor. The four S5-S6 linkers
(also called “P-loop” [for pore-loop]) line the inner part
of the ionic pore. How do these T666M, V715E, and
I1811L substitutions alter P/Q-type calcium currents and
result in the permanent cerebellar dysfunction charac-
teristic of the HM/PCA phenotype?
The three HM/PCA mutations are neither clustered in
a specific part of the a1A subunit nor located in ho-
mologous segments within the four repeated domains:
The T666M mutation is located in the S5-S6 linker of
domain II, the D715E mutation alters the residue located
just after the intracytoplasmic end of IIS6, and the
I1811L substitution is located at the intracytoplasmic
end of the IVS6 helix. The HM/PCA phenotype could
be due to a shared functional effect of these substitutions
located in different channel parts. Recently, using ex-
pression of mutant a1A subunits in Xenopus laevis oo-
cytes, Kraus et al. (1998) demonstrated that both
T666M and I1811L mutations change the channel’s in-
activation kinetics. However, the T666M mutation was
shown to slow recovery from inactivation and the
I1811L mutation to accelerate recovery from inactiva-
tion. Consequently, a similar clinical phenotype may be
due to mutations showing distinct functional conse-
quences, at least in Xenopus oocytes.
One would have expected mutations causing pure HM
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Figure 3 a1A subunit missense mutations causing HM/PCA and pure HM. A schematic structure of the a1A calcium channel subunit
is drawn, and positions of all HM causing mutations identified thus far are indicated.
Table 4
Observed CACNA1A Coding Sequence Polymorphisms
Exon
Nucleotide
Change
Amino-acid
Change
Heterozygous
Index Case
Frequency
in 50 Controls
4 acGracA Thr193 F10 .02
a
6 gaArgaG Glu292 F5 .07
a
16 acGracA Thr698 F15 .12
a
20 GgcrAgc Gly1105ser F2 .25b
a Ophoff et al. 1996.
b Present study.
to have different functional consequences than muta-
tions causing HM/PCA. Only two mutations have been
identified thus far in two pure HM families: R192Q and
V714A (Ophoff et al. 1996). For the R192Q substitu-
tion, which removes a positive charge in the IS4 voltage
sensor, no electrophysiologic change was observed
(Kraus et al. 1998). Surprisingly, the V714A mutation,
located at the intracytoplasmic end of IIS6, was shown
to accelerate recovery from inactivation similarly to the
HM/PCA-associated I1811L mutation (Kraus et al.
1998). In addition, the V714A mutation is adjacent to
the newly identified HM/PCA-causing mutation D715E.
The presence of cerebellar symptoms may have been
overlooked in the V714A family. Indeed, those symp-
toms have an incomplete penetrance, as demonstrated
by the normal neurologic findings on examination of 19
patients within the 16 families studied herein. Moreover,
the severity of symptoms is highly variable, ranging from
an isolated nystagmus to a marked ataxia within patients
from a given family.
What are the molecular mechanisms susceptible to
modulate the functional consequences of a given mu-
tation on neuronal P/Q- type calcium currents? The a1A
subunit is the pore-forming structure of P- and Q-type
channels, which have distinct pharmacologic and elec-
trophysiologic properties and a different neuronal dis-
tribution. (Mori et al. 1991; Stea et al. 1994; Westen-
broek et al. 1995; Moreno et al. 1997). Indeed, P-type
channels represent the major calcium channel compo-
nent in Purkinje cells, P- and Q-types have been dem-
onstrated to coexist in cultured cerebellar granule neu-
rons, and Q-type channels are predominant in the
control of neurotransmitter release in hippocampal neu-
rons (Wheeler et al. 1994, 1995). How do a1A subunits
produce this diversity of currents? It has been shown
that alternative splicing generates a1A subunits with dis-
tinct subcellular localization, biochemical, and electro-
physiologic properties (Sakurai et al. 1996). In addition,
the same a1A isoform coexpressed with different ancil-
lary b subunits in a mammalian cell line gives rise to
distinct types of currents (Moreno et al. 1997). A
CACNA1A mutation may have differential effects on
the various generated calcium currents, depending on
the a1A splice variant or on the combination of asso-
ciated auxiliary subunits forming the channel. Pure HM-
associated mutations could have no effect on cerebellar
a1A calcium currents, whereas HM/PCA-associated mu-
tations might alter both cerebellar and noncerebellar
a1A calcium currents.
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